Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thenmalar Vadiveloo

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
European Urology Oncology|May 13, 2026
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled TrialsWei Shen Tan, Ashish M Kamat, Rebecca Lewis, et al.
Health Technology Assessment (Winchester, England)|May 5, 2021
Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCTSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
Lancet (London, England)|November 15, 2020
Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trialSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
ERJ Open Research|March 12, 2024
SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trialMerete B Long, Hani Abo-Leyah, Yan Hui Giam, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder CancerRakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al.
Health Technology Assessment (Winchester, England)|October 27, 2022
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCTRakesh Heer, Rebecca Lewis, Anne Duncan, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Urology Oncology|May 13, 2026
Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled TrialsWei Shen Tan, Ashish M Kamat, Rebecca Lewis, et al.
Health Technology Assessment (Winchester, England)|May 5, 2021
Provision of the progestogen-only pill by community pharmacies as bridging contraception for women receiving emergency contraception: the Bridge-it RCTSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
Lancet (London, England)|November 15, 2020
Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trialSharon T Cameron, Anna Glasier, Lisa McDaid, et al.
ERJ Open Research|March 12, 2024
SFX-01 in hospitalised patients with community-acquired pneumonia during the COVID-19 pandemic: a double-blind, randomised, placebo-controlled trialMerete B Long, Hani Abo-Leyah, Yan Hui Giam, et al.
NEJM Evidence|February 6, 2024
A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder CancerRakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al.
Health Technology Assessment (Winchester, England)|October 27, 2022
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCTRakesh Heer, Rebecca Lewis, Anne Duncan, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
Pageof 4